These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 8551407

  • 1. Treatment of immune globulin-resistant Kawasaki disease with pulsed doses of corticosteroids.
    Wright DA, Newburger JW, Baker A, Sundel RP.
    J Pediatr; 1996 Jan; 128(1):146-9. PubMed ID: 8551407
    [Abstract] [Full Text] [Related]

  • 2. Randomized trial of pulsed corticosteroid therapy for primary treatment of Kawasaki disease.
    Newburger JW, Sleeper LA, McCrindle BW, Minich LL, Gersony W, Vetter VL, Atz AM, Li JS, Takahashi M, Baker AL, Colan SD, Mitchell PD, Klein GL, Sundel RP, Pediatric Heart Network Investigators.
    N Engl J Med; 2007 Feb 15; 356(7):663-75. PubMed ID: 17301297
    [Abstract] [Full Text] [Related]

  • 3. Re-treatment for immune globulin-resistant Kawasaki disease: a comparative study of additional immune globulin and steroid pulse therapy.
    Hashino K, Ishii M, Iemura M, Akagi T, Kato H.
    Pediatr Int; 2001 Jun 15; 43(3):211-7. PubMed ID: 11380911
    [Abstract] [Full Text] [Related]

  • 4. The use of corticosteroid therapy in refractory Kawasaki patients.
    Al-Mayouf SM.
    Clin Rheumatol; 2004 Feb 15; 23(1):11-3. PubMed ID: 14749974
    [Abstract] [Full Text] [Related]

  • 5. Pulse methylprednisolone therapy in the treatment of immune globulin-resistant Kawasaki disease: case report and review of the literature.
    Hung JJ, Chiu CH.
    Ann Trop Paediatr; 2004 Mar 15; 24(1):89-93. PubMed ID: 15005973
    [Abstract] [Full Text] [Related]

  • 6. The strategy of immune globulin resistant Kawasaki disease: a comparative study of additional immune globulin and steroid pulse therapy.
    Ogata S, Bando Y, Kimura S, Ando H, Nakahata Y, Ogihara Y, Kaneko T, Minoura K, Kaida M, Yokota Y, Furukawa S, Ishii M.
    J Cardiol; 2009 Feb 15; 53(1):15-9. PubMed ID: 19167633
    [Abstract] [Full Text] [Related]

  • 7. [Methylprednisolone pulse therapy in Kawasaki disease].
    Miura M, Matsuoka M, Kohno K, Ohki H, Yoshiba S.
    Nihon Rinsho; 2008 Feb 15; 66(2):338-42. PubMed ID: 18265457
    [Abstract] [Full Text] [Related]

  • 8. Methylprednisolone pulse therapy for massive lymphadenopathy in a child with intravenous immunoglobulin-resistant Kawasaki disease.
    Chen HH, Liu PM, Bong CN, Wu YT, Yang KD, Wang CL.
    J Microbiol Immunol Infect; 2005 Apr 15; 38(2):149-52. PubMed ID: 15843862
    [Abstract] [Full Text] [Related]

  • 9. Response of refractory Kawasaki disease to intravenous methylprednisolone.
    Shah I, Prabhu SS.
    Ann Trop Paediatr; 2009 Mar 15; 29(1):51-3. PubMed ID: 19222935
    [Abstract] [Full Text] [Related]

  • 10. Effects of steroid pulse therapy on immunoglobulin-resistant Kawasaki disease.
    Furukawa T, Kishiro M, Akimoto K, Nagata S, Shimizu T, Yamashiro Y.
    Arch Dis Child; 2008 Feb 15; 93(2):142-6. PubMed ID: 17962370
    [Abstract] [Full Text] [Related]

  • 11. The Clinical Utility and Safety of a New Strategy for the Treatment of Refractory Kawasaki Disease.
    Ebato T, Ogata S, Ogihara Y, Fujimoto M, Kitagawa A, Takanashi M, Ishii M.
    J Pediatr; 2017 Dec 15; 191():140-144. PubMed ID: 29173297
    [Abstract] [Full Text] [Related]

  • 12. [Steroid pulse therapy].
    Miura M.
    Nihon Rinsho; 2014 Sep 15; 72(9):1631-5. PubMed ID: 25518414
    [Abstract] [Full Text] [Related]

  • 13. Response of refractory Kawasaki disease to pulse steroid and cyclosporin A therapy.
    Raman V, Kim J, Sharkey A, Chatila T.
    Pediatr Infect Dis J; 2001 Jun 15; 20(6):635-7. PubMed ID: 11419513
    [Abstract] [Full Text] [Related]

  • 14. Primary treatment of incomplete Kawasaki disease with infliximab and methylprednisolone in a patient with a contraindication to intravenous immune globulin.
    Shirley DA, Stephens I.
    Pediatr Infect Dis J; 2010 Oct 15; 29(10):978-9. PubMed ID: 20431427
    [Abstract] [Full Text] [Related]

  • 15. Infliximab for intensification of primary therapy for Kawasaki disease: a phase 3 randomised, double-blind, placebo-controlled trial.
    Tremoulet AH, Jain S, Jaggi P, Jimenez-Fernandez S, Pancheri JM, Sun X, Kanegaye JT, Kovalchin JP, Printz BF, Ramilo O, Burns JC.
    Lancet; 2014 May 17; 383(9930):1731-8. PubMed ID: 24572997
    [Abstract] [Full Text] [Related]

  • 16. Is there a role for corticosteroids in Kawasaki disease?
    Shulman ST.
    J Pediatr; 2003 Jun 17; 142(6):601-3. PubMed ID: 12838185
    [No Abstract] [Full Text] [Related]

  • 17. Standard-dose and short-term corticosteroid therapy in immunoglobulin-resistant Kawasaki disease.
    Takeshita S, Kawamura Y, Nakatani K, Tsujimoto H, Tokutomi T.
    Clin Pediatr (Phila); 2005 Jun 17; 44(5):423-6. PubMed ID: 15965549
    [Abstract] [Full Text] [Related]

  • 18. Resistant Kawasaki disease.
    Nachiappan J, May M, Hawker RE, Hong P.
    J Paediatr Child Health; 2004 Jun 17; 40(9-10):576-8. PubMed ID: 15367156
    [No Abstract] [Full Text] [Related]

  • 19. [Evaluation of unresponsiveness to standard high-dose gamma globulin therapy in Kawasaki disease].
    Tavli V, Yilmazer MM, Güven B, Meşe T, Oner T, Demirpençe S.
    Turk Kardiyol Dern Ars; 2010 Jan 17; 38(1):20-4. PubMed ID: 20215838
    [Abstract] [Full Text] [Related]

  • 20. Pulse methylprednisolone therapy for impending cardiac tamponade in immunoglobulin-resistant Kawasaki disease.
    Dahlem PG, von Rosenstiel IA, Lam J, Kuijpers TW.
    Intensive Care Med; 1999 Oct 17; 25(10):1137-9. PubMed ID: 10551972
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.